Product
AmBisome
Name
AmBisome
INN Name
amphotericin B
FDA Approved
Yes
2 clinical trials
1 organization
3 indications
1 document
Indication
Invasive Fungal InfectionsIndication
FeverIndication
bioequivalenceClinical trial
Bioequivalence Study to Evaluate Pharmacokinetics and Safety of AmBisome and DKF-5122 in Indicated Patients and Healthy AdultsStatus: Completed, Estimated PCD: 2022-01-28
Clinical trial
A Randomized, Open-label, Single-dose, Two-preparation, Two-period, Two-sequence Bioequivalence Study Between Amphotericin B Liposome for Injection and AmBisome® in Healthy SubjectsStatus: Completed, Estimated PCD: 2023-09-01
Document
DailyMed Label: AmBisomeOrganization
Astellas Pharma US, Inc.